Valproate

Valproate: How It Works, Monitoring & the Warnings for Women

Valproate is a broad-spectrum antiepileptic and at the same time a mood stabiliser for bipolar disorder. It counts as particularly effective in certain seizure types, but it is subject to the strictest restrictions on use that exist in Germany for a medicine of this group: in girls and women of childbearing potential it may only be used under the conditions of a pregnancy prevention programme of its own. On top of that come regular checks of the liver values, the blood count and ammonia.

See more detail

Take valproate reliably at the same time every day

A dosing reminder, your laboratory history and an interaction check in one place — free in the brite app.

Track valproate

1. At a Glance: Technical Data Sheet

PropertyDetails
Active ingredientValproic acid, used also as sodium valproate or as a combination of both forms
ATC codeN03AG01
Drug classBroad-spectrum antiepileptic; at the same time a mood stabiliser used to prevent further episodes
Dosage formsProlonged-release tablets and prolonged-release granules, gastro-resistant tablets, an oral liquid, drops, solution for infusion
Half-lifeIn adults usually about 10 to 20 hours; shorter in children, longer where there is liver disease
DosingStarted low, increased individually and adjusted to effect and tolerability; the maximum dose follows the SmPC, body weight and the indication
Onset of effectProtection against seizures over days to weeks; the mood-stabilising effect takes longer
BreakdownPredominantly in the liver; strongly bound to proteins in the blood — several interactions follow from that
Prescription statusPrescription-only medicine
Notable featureA strict restriction on use in girls and women of childbearing potential: use only within the pregnancy prevention programme, with annual confirmation that the risks have been explained
Table scrolls to the right

2. How it works: what valproate does in the brain

An epileptic seizure arises when nerve cells in the brain can no longer brake their activity sufficiently and fire together in a state of over-excitation. Valproate acts at several points at once to balance out this excess of excitation.¹

  • More braking: valproate increases the availability of GABA, the inhibitory messenger substance in the brain. GABA is, so to speak, the handbrake of the nervous system.
  • Less accelerator: it also acts on ion channels in the cell membrane, through which nerve cells discharge again and again. Bursts of rapid discharges are damped down as a result.
  • A broad spectrum of action: because valproate does not act at a single point only, it works in very different seizure types — including generalised seizures, in which some other substances fail or can even make the seizures worse.

That same broad attack also explains the profile of side effects: tiredness, trembling and the effects on metabolism are no accident but the flip side of a drug that influences many systems at once.


3. Uses: epilepsy, bipolar disorder, migraine

Valproate has three fields of use, and they carry very different weight.

  • Epilepsy: the main area of use. In generalised forms of epilepsy valproate counts as particularly effective and, according to the guideline, remains a first-choice medicine in men and in women for whom a pregnancy is not possible.²
  • Bipolar disorder: for treating manic episodes and for preventing further episodes, where other options are out of the question or do not work well enough.
  • Preventing migraine: only in exceptional cases and outside the licence; it is not envisaged for women of childbearing potential. There are usually better-suited alternatives.
Why the choice looks different today than it did twenty years ago. The evidence for how well it works is unchanged. What has changed is the knowledge about the risks in pregnancy. That is why, in girls and women of childbearing potential, the first question today is whether another substance — lamotrigine or levetiracetam, for instance — is an option. Only where that is not possible does valproate come into consideration, under the conditions set out in section 7.

4. Dosing: starting low, prolonged-release forms and preparations

The details below describe the usual approach according to the SmPC. They are not a dosing instruction — the dose, the target range and any adjustments are set by the treating practice.¹

  • Starting low: treatment begins at a low dose and is increased step by step until freedom from seizures or a stable mood is reached. Increasing too quickly adds above all to tiredness and stomach complaints.
  • Prolonged-release preferred: prolonged-release forms release the drug gradually. That flattens the peaks in the blood, reduces side effects and often allows the medicine to be taken once or twice a day.
  • Do not confuse the forms: prolonged-release tablets, gastro-resistant tablets and the oral liquid are not simply interchangeable. A change of dosage form belongs in medical hands, not to a decision of your own at the pharmacy counter.
  • Split only where it is allowed: prolonged-release tablets may only be split where the SmPC expressly provides for it. Crushing destroys the prolonged release. Background in the guide splitting tablets.

5. Taking it: timing, the stomach, a missed dose

  1. Pick fixed times. With epilepsy, an even blood level is the most important protection against breakthrough seizures; taking the medicine irregularly is one of the commonest causes of seizures returning.
  2. With or after food. Stomach complaints and nausea occur less often when it is not taken on an empty stomach.
  3. With water, not with alcohol. Alcohol adds to tiredness and can lower the seizure threshold in epilepsy — particularly during withdrawal. Details in the guide medications and alcohol.
  4. A missed dose: as a rule it is made up if the gap to the next dose is big enough; a double amount is not the answer. What applies generally is set out in the guide missing a medication.
  5. Report vomiting shortly after a dose. Whether a further dose is given depends on how much time has passed — a question for your practice or pharmacy, not for guesswork.
Driving and operating machinery. Above all while the dose is being settled, tiredness, trembling and problems with concentration can impair your fitness to drive. With epilepsy there are also rules of their own on fitness to drive, and they depend on being free of seizures. Raise this actively — background in the guide medications and driving.

No more forgotten doses

With antiepileptics, regularity is the best protection — brite reminds you reliably.

Set up a reminder

6. Side effects and what helps against them

Common and usually manageable

  • Trembling of the hands: a fine tremor is typical and often depends on the dose; caffeine and lack of sleep make it worse. If it disturbs your everyday life, it is worth talking about adjusting the dose.
  • Weight gain and an increased appetite: one of the commonest burdens, and a common reason for stopping the drug in secret. Countering it early is easier than losing several kilos later on.
  • Hair loss: usually diffuse, and often receding after a few months; regrowing hair can change in texture or colour. There is no evidence that zinc or selenium preparations help — food supplements only after talking to your practice, see supplements and medications.
  • Tiredness, drowsiness and stomach and bowel complaints: above all at the start and after the dose has been increased; nausea can be eased by taking the medicine with food.

Rarer, but important to know about

  • Liver damage: rare, but potentially serious — particularly in the first six months and in small children. See the danger box below.
  • Inflammation of the pancreas: very rare; it announces itself with severe pain in the upper abdomen, nausea and vomiting, and it is an emergency.
  • Changes in the blood count: above all a fall in the platelets, which increases the tendency to bleed — which is why the blood count is one of the things monitored.
  • Raised ammonia in the blood: can lead to confusion, drowsiness and changes in behaviour, even where the liver values are unremarkable.
  • Hormonal changes: disturbances of the menstrual cycle and signs of polycystic ovary syndrome have been described.
Early signs of liver damage — particularly in the first months. Severe liver damage usually announces itself not through the liver values but through general complaints: increasing tiredness and weakness, loss of appetite, repeated vomiting, pain in the upper abdomen, seizures suddenly returning. Also alarming are yellowing of the skin or eyes, unusual bruising and water retention. These signs need medical assessment without delay — do not wait with them until your next routine appointment. If there is marked drowsiness or impaired consciousness, call 112 (emergency services in Germany).

7. The pregnancy prevention programme: what women need to know

This is the most important section of the whole article. It is written factually, not alarmingly — but it leaves nothing out.

Valproate is the substance with the highest known risk to the unborn child among the antiepileptics in common use. The German Federal Institute for Drugs and Medical Devices (BfArM) has laid down mandatory educational material and a pregnancy prevention programme for it.³

What this is about in concrete terms

  • Malformations: where it is taken during pregnancy, physical malformations — among them neural tube defects and malformations of the heart, the face and the limbs — occur markedly more often than with other antiepileptics. According to the figures in the BfArM educational material, around one child in ten is affected.
  • Developmental disorders: in a considerable proportion of the children exposed to valproate in the womb, developmental disorders occur — delayed speech development, lower cognitive performance, an increased risk of autism spectrum disorders and of ADHD. These consequences often only become apparent at nursery or school age.
  • No safe period: the risk does not exist in the first third of pregnancy alone. Taking it later can also affect the development of the brain.

What the programme requires

  1. Use only where nothing else works. In girls and women of childbearing potential, valproate may only be used where other treatments are ineffective or not tolerated. In bipolar disorder, use during pregnancy is ruled out.
  2. Effective contraception throughout the whole treatment. A reliable method is required — in case of doubt a long-acting method such as a coil or an implant is superior to the pill, because it cannot be forgotten. What to bear in mind when medicines and contraception come together is set out in the guide medications and contraception; there is a separate article on the pill.
  3. Annual counselling and a confirmation form. The treating specialist discusses the risks with you at least once a year; both of you sign a form confirming that the risks have been explained. That is not a formality but a precondition of the prescription.
  4. A patient card and warnings on the pack. The programme includes a patient card and a warning with a symbol on the outer packaging. The pharmacy is required to point this out each time the medicine is handed over.
  5. Pregnancy tests before treatment starts and during it are likewise part of the intended procedure.
If you are pregnant or would like to become pregnant. Do not stop valproate on your own — a sudden stop can trigger severe seizures, which are dangerous for mother and child as well. Instead, get in touch with your treating practice without delay, so that a switch can be planned. A pregnancy on valproate is not left to itself but looked after closely. Orientation is offered by the guide medications during pregnancy and by the independent advice of Embryotox.
Relevant for men too. For men who father a child while taking valproate, possible risks to the children have been discussed and taken up in regulatory safety information. The data on this are limited and the assessment is not complete. If you are a man and would like to have a child, raise it — that is a sensible question, not excessive caution.

8. Interactions: carbapenems, lamotrigine, aspirin

Valproate is a substance with many interactions. Two properties explain almost all of them: it is strongly bound to proteins in the blood, and it influences the breakdown of other medicines in the liver.

CombinationConsequenceWhat to do
Carbapenem antibiotics (e.g. meropenem, imipenem)The valproate level falls drastically within a few days — a risk of seizuresThe combination is avoided where possible; where it cannot be avoided, close monitoring of the level and of seizures in hospital
LamotrigineValproate slows the breakdown, the lamotrigine level rises — a higher risk of severe skin reactionsThe combination is established and often sensible, but it needs a markedly slower increase of the lamotrigine dose
Aspirin (acetylsalicylic acid)Displaces valproate from its protein binding, so the freely active proportion rises; on top of that the effects on the platelets add upNot for self-medication; discuss the choice of painkiller. Paracetamol is frequently the more straightforward option
Other antiepileptics that stimulate the liver's metabolismThe valproate level can fall, their own levels riseChanges belong in specialist hands
Anticoagulants and platelet inhibitorsAn increased tendency to bleedKeep an eye on the blood count and clotting, raise it before procedures
Sedatives and sleeping tablets, antipsychoticsIncreased tiredness and drowsinessCombine only deliberately; reassess fitness to drive
AlcoholMore tiredness, a strain on the liver, a lower seizure threshold during withdrawalRestraint, particularly with epilepsy
Table scrolls to the right

The three points that matter most in practice, in plain words:

  • Carbapenems: these antibiotics are used in hospital for severe infections, and they lower the level so quickly that raising the dose hardly makes up for it. On admission to hospital, valproate therefore belongs visibly on the medication plan — not in your memory.
  • Lamotrigine: the combination is not forbidden, quite the opposite — it is used deliberately. What is decisive is that lamotrigine is increased far more slowly and to lower doses than on its own; increasing too quickly raises the risk of severe skin reactions.
  • Aspirin: available without a prescription, but not harmless: besides displacing valproate from its protein binding, both substances act on the platelets. For a headache, paracetamol is usually the simpler choice — see painkillers compared.

Because the list is long and not complete, it is worth a cross-check with every new preparation — including ones sold over the counter. The guide drug interactions and the interaction check in the brite app both help with that.


9. Monitoring: liver values, blood count, ammonia and the blood level

Valproate is accompanied by laboratory checks. What matters is to understand what each of the values can do — and what it cannot.

  • Liver values: before treatment starts, and afterwards regularly, especially during the first six months. A slight, temporary rise is known about and not automatically threatening; what is decisive is the overall picture of values and complaints.
  • Blood count including the platelets: the platelets are often the first thing to become abnormal, frequently without your noticing anything — except perhaps more frequent bruises or bleeding gums.
  • Clotting before an operation: before procedures and larger dental treatments, valproate belongs in the conversation, see medications before surgery.
  • Ammonia: measured specifically where unusual tiredness, confusion or changes in behaviour occur. A raised value can be present even when the liver values are normal — which is why the complaints count for more here than the routine finding.

The blood level: helpful, but only so telling

Unlike with some other substances, measuring the blood level of valproate is not a steering instrument for the dose. The laboratory records the total level, but only the proportion not bound to protein is active — and that proportion varies, for instance where the protein in the blood is low, in kidney disease, in older age or on aspirin.

So the rule is: what is treated is the person, not the laboratory value. The level is useful for checking whether the medicine is being taken as prescribed, for recognising interactions or for narrowing down an overdose. Whether the dose is right is decided by freedom from seizures, stability of mood and tolerability — see also understanding blood values.

Bring the history with you, not just the latest slip of paper. A single liver value says little; three values over six months say a lot. If you collect laboratory values, seizure days and side effects in one place, the conversation at your next appointment becomes more concrete — preparing for a doctor's appointment offers help with that.

10. Special situations: the liver, older age, children, alcohol

Liver disease. In severe liver disease and in certain inherited metabolic disorders, valproate is not suitable; a family history of unexplained liver damage in childhood also belongs in the conversation beforehand. Where there is fatty liver, particular attention makes sense, because changes in the liver values are then harder to attribute. The general picture is set out in the guide medications for kidney and liver disease.

Small children. The risk of severe liver damage is highest in children under three years of age, particularly where several antiepileptics are used at the same time. Treatment here is therefore especially cautious and accompanied by close monitoring, see children and medications.

Older age. Older people react more sensitively to tiredness, unsteadiness of gait and confusion. The protein in the blood is often lower as well, so the active free proportion rises without the total level looking abnormal — see medications in old age and polypharmacy.

Alcohol. It puts an additional strain on the liver, adds to tiredness and lowers the seizure threshold during withdrawal — a subject that belongs in the open, without moralising, but with clear facts.


11. Stopping: why never abruptly

Stopping valproate abruptly can trigger severe seizures in epilepsy, up to status epilepticus — a prolonged seizure, which is an emergency. In bipolar disorder a sudden stop raises the risk of a rapid relapse.

Never on your own. Even if you have been free of seizures for years or the side effects are a burden: stopping is planned, tapered slowly and accompanied — often over months. Freedom from seizures is precisely the result of the treatment, not its end. How such a process generally works is described in the guide stopping medications.

Switching to another substance is not an exchange from one day to the next either: as a rule the new medicine is increased while the old one is slowly reduced — with a period of overlap. Where the switch is being made because you want a child, this planning ideally begins months in advance. For everyday life with a chronic condition, chronic illness in everyday life is also worth reading.


12. Valproate experiences: what patients really ask

"I have been taking this for years and knew nothing about the risks in pregnancy"

That does happen, particularly with treatments that were started many years ago. Today's requirements were only introduced step by step. What matters is not the look back but the next step: if you are a woman of childbearing potential and you take valproate, make an appointment specifically to review it. Two questions are at stake — whether a switch is possible and, if not, whether the conditions of the prevention programme are met. Both can be settled in one conversation. In the meantime, stop nothing.

"My hair is falling out — will it stop?"

Hair loss on valproate is usually diffuse, that is, spread over the whole head, and in many of those affected it recedes after a few months. Some report that regrowing hair is curlier or a different colour. There is no sound evidence that zinc or selenium preparations help. What does help is clearing up other causes: iron deficiency and thyroid disorders are common and are easily overlooked under the heading "it's the medicine".

"I am putting on weight although I am not eating more than before"

Weight gain on valproate has several components: an increased appetite, changes in metabolism and sometimes water retention. The honest answer is that this cannot always be solved by discipline alone — and that it is nevertheless worth countering it early rather than later. If the gain is marked, or if it is making you think about stopping, it belongs on the table: there are alternatives, and the decision should be taken together, not in secret.

"Do I really have to sign this form every year?"

Yes, that is part of a procedure laid down by the authorities and not a piece of red tape invented by the practice. The point of it: information about risks fades with time, and life situations change — a woman for whom having a child was not on the cards five years ago may be planning differently today. The annual conversation is the moment when exactly that is looked at again. Use it actively and bring your questions with you.

Been given a new medicine? Check it first.

The interaction check shows critical combinations before you take them.

Check a combination

FAQ: Common questions about valproate

Taken during pregnancy, valproate markedly increases the risk of physical malformations and of developmental disorders in the child. That is why a pregnancy prevention programme laid down by the BfArM applies in Germany: use only where other treatments are ineffective or not tolerated, combined with effective contraception and annual counselling with a signature. The decision is taken by the treating specialist together with you.
Do not stop the medicine on your own, because a sudden stop can trigger severe seizures, which are dangerous for mother and child as well. Get in touch with your treating practice without delay so that the next steps can be planned. An independent assessment is offered in addition by the Embryotox advisory centre.
Typical are increasing tiredness and weakness, loss of appetite, repeated vomiting, pain in the upper abdomen and seizures suddenly returning, particularly during the first six months of treatment. Also alarming are a yellowing of the skin or eyes, unusual bruising and water retention. These signs need medical assessment without delay and should not be put off until the next routine appointment.
Only to a limited extent. The laboratory as a rule measures the total level, but what is active is the proportion not bound to protein, and that proportion varies. The level helps to check whether the medicine is being taken as prescribed, to recognise interactions or to narrow down an overdose. Whether the dose is right is decided by freedom from seizures, stability of mood and tolerability.
Yes, this combination is used deliberately and is established. Valproate does, however, slow the breakdown of lamotrigine, so its level rises and the risk of severe skin reactions increases. That is why lamotrigine is increased far more slowly and to lower doses in this combination than on its own. Report any newly appearing skin rash immediately.
No. Stopping abruptly can trigger severe seizures, up to status epilepticus, which is an emergency. Freedom from seizures is as a rule the result of the treatment, not its end. Where stopping is a medical option, it is planned, tapered very slowly and accompanied by a doctor.

Sources

  1. Summaries of Product Characteristics (SmPCs) for valproate-containing medicines (current version, available through the German medicines information system). pharmnet-bund.de
  2. S2k guideline "First epileptic seizure and epilepsies in adulthood" (German Neurological Society, AWMF reg. no. 030-041, current version) — German source. awmf.org
  3. BfArM (Germany's federal institute for drugs and medical devices): educational material and pregnancy prevention programme for valproate, safety notices to prescribers. Accessed 2026 — German source. bfarm.de
  4. Embryotox, Charité — German pharmacovigilance and advisory centre on embryonic toxicology: valproate in pregnancy and breastfeeding. Accessed 2026. embryotox.de
  5. Gesundheitsinformation.de (IQWiG): Epilepsy and bipolar disorder — treatment with medicines. Accessed 2026 — German source. gesundheitsinformation.de
  6. German S3 guideline on the diagnosis and treatment of bipolar disorders (DGBS and DGPPN, AWMF reg. no. 038-019, current version) — German source. awmf.org
  7. gesund.bund.de: Epilepsy. Accessed 2026 — German source. gesund.bund.de

Manage valproate safely in everyday life — with brite

A dosing reminder, your laboratory history and an interaction check in one place. Free.

Create medication plan
brite App
Medical disclaimer: This article is for general information and does not replace medical advice, diagnosis or treatment. Never stop valproate on your own and do not change the dose yourself — an abrupt stop can trigger severe seizures, up to status epilepticus. In girls and women of childbearing potential, valproate may only be used under the conditions of the pregnancy prevention programme; if you are pregnant or planning a pregnancy, contact your treating practice without delay. If there are signs of liver damage such as increasing tiredness, loss of appetite, repeated vomiting or a yellowing of the skin and eyes, seek medical help without delay; in an emergency call 112 (emergency services in Germany). The choice of medicine and the dose are always set individually by the treating practice. Last updated: August 2026.